- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aptose Biosciences Inc (APTOF)
Aptose Biosciences Inc stock price live, this page displays TSX APS stock exchange data. View the APS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aptose Biosciences Inc real time stock price chart below.
What Is the Aptose Biosciences Inc Stock Price Today?
The Aptose Biosciences Inc stock price today is 1.430.
What Is the Stock Symbol for Aptose Biosciences Inc?
The stock symbol for Aptose Biosciences Inc is ""APS.""
What Stock Exchange Does Aptose Biosciences Inc Trade On?
Aptose Biosciences Inc is listed and trades on the Toronto stock exchange.
Is Aptose Biosciences Inc a Good Stock to Buy?
Determining whether Aptose Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APS quote. (ISIN: CA03835T4081)
What Is the Aptose Biosciences Inc Stock Price Today?
The Aptose Biosciences Inc stock price today is 1.430.
What Is the Stock Symbol for Aptose Biosciences Inc?
The stock symbol for Aptose Biosciences Inc is ""APS.""
What Stock Exchange Does Aptose Biosciences Inc Trade On?
Aptose Biosciences Inc is listed and trades on the Toronto stock exchange.
Is Aptose Biosciences Inc a Good Stock to Buy?
Determining whether Aptose Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APS quote. (ISIN: CA03835T4081)
1.430
-0.110(-7.15%)
Delayed Data·
Fair Value
An estimate of a Aptose Biosciences Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.390
1.640
52 wk Range
0.636
17.400
APTOF Scorecard
Full Analysis
May have trouble making interest payments on debt
APTOF is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Aptose Biosciences Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3901.640
52 wk Range
0.63617.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
APTOF Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Aptose Biosciences Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Aptose Provides Corporate Updates
- Investing.com
- Aptose Provides Corporate Updates
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Aptose Biosciences Inc Company Profile
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company’s clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloid malignancies, such as acute myeloid leukemia and the higher risk myelodysplastic syndromes; and luxeptinib (CG-806), a potent oral small molecule, which is in Phase 1 a/b clinical trial in patients with relapsed or refractory B cell malignancies, including chronic lymphocytic leukemia, and certain non-Hodgkin’s lymphomas, as well as relapsed or refractory acute myeloid leukemia. It has license agreements with CrystalGenomics Invites Co. Ltd. to research, develop, and commercialize luxeptinib; with National Cancer Institute for the clinical development of tuspetinib; and Hanmi Pharmaceutical Co Ltd. to research, develop, and commercialize tuspetinib. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
Compare APTOF to Peers and Sector
Metrics to compare | APTOF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPTOFPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −2.8x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | −0.5x | −0.3x | 2.6x | |
Price / LTM Sales | - | 3.3x | 3.2x | |
Upside (Analyst Target) | - | 66.7% | 41.2% | |
Fair Value Upside | Unlock | 10.4% | 6.2% | Unlock |
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-2.61 / -0.99
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Aptose Biosciences Inc Trade On?
Aptose Biosciences Inc is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Aptose Biosciences Inc?
The stock symbol for Aptose Biosciences Inc is "APTOF."
What Is the Aptose Biosciences Inc Market Cap?
As of today, Aptose Biosciences Inc market cap is 3.67M.
What Is Aptose Biosciences Inc's Earnings Per Share (TTM)?
The Aptose Biosciences Inc EPS (TTM) is -19.03.
From a Technical Analysis Perspective, Is APTOF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aptose Biosciences Inc Stock Split?
Aptose Biosciences Inc has split 4 times.
How Many Employees Does Aptose Biosciences Inc Have?
Aptose Biosciences Inc has 13 employees.
What is the current trading status of Aptose Biosciences Inc (APTOF)?
As of 29 Jul 2025, Aptose Biosciences Inc (APTOF) is trading at a price of 1.43, with a previous close of 1.54. The stock has fluctuated within a day range of 1.39 to 1.64, while its 52-week range spans from 0.64 to 17.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.